Strategy

News

GSK must continue to improve R&D, says CEO Walmsley

It’s been two and a half years since Emma Walmsley took over as CEO of GlaxoSmithKline, and at the time was seen as the protégé of her predecessor Sir Andrew Witty.

Partner Content

Partner Content

Kristin Milburn joins Healthware Group as Global Head of Dig...

We are pleased to announce Kristin Milburn has joined

Partner Content

Partner Content

Three strategies for managing loss of exclusivity successful...

Effectively planning your LOE strategy

Events

Partner Content

8th Annual Pharma CI Europe Conference & Exhibition

The Best Assembly of Competitive Intelligence Experts

Partner Content

Partner Content

Prescient Healthcare Group Strengthens Its US Leadership Tea...

Dr. Paul Harney Joins the Prescient Team

Partner Content

How to create an integrated social media and digital strateg...

Social Media in Pharma

GSK must continue to improve R&D, says CEO Walmsley

Kristin Milburn joins Healthware Group as Global Head of Dig...

Three strategies for managing loss of exclusivity successful...

8th Annual Pharma CI Europe Conference & Exhibition

Prescient Healthcare Group Strengthens Its US Leadership Tea...

How to create an integrated social media and digital strateg...

Iambic prices its IPO, seeking to raise up to $160m

Discover a new era of healthcare panel engagement: Grounded ...

Strategy

Editor's Picks